RESATORVID
Alcoholic Hepatitis
Yaqrit LtdSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Alcoholic Hepatitis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
N-Acetyl-L-Cysteine Centre Hospitalier Universitaire, Amiens | Phase 3 | BB |
MG-2 PharmaKing | Phase 2 | B |
Metadoxine PharmaKing | Phase 2 | B |
Selonsertib Gilead Sciences | Phase 2 | B |
PEGFILGRASTIM Timothy Morgan, MD | Phase 2 | B |
View all 11 →
Same molecule, other indications
RESATORVID is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →